USPTO Examiner PORTER RACHEL L - Art Unit 3626

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17091673SYSTEMS AND METHODS FOR SUPPLEMENTING AN ELECTRONIC MEDICAL RECORDNovember 2020June 2023Abandon3210NoNo
17042885SKIN HEALTH TRACKERSeptember 2020November 2022Abandon2620YesNo
17008420Healthcare Malpractice ControlAugust 2020April 2023Abandon3110NoNo
16986702METHOD AND DEVICE FOR IDENTIFYING CLUES ABOUT MEDICAL ADVERSE EVENTS, ELECTRONIC EQUIPMENT, AND MEMORY MEDIUMAugust 2020October 2023Abandon3820NoNo
16920214DYNAMIC SCHEDULING OF THE DISTRIBUTION OF MEDICAL EQUIPMENTJuly 2020November 2023Abandon4020NoNo
16863285Mobile Intelligent Injury Minimization System and MethodApril 2020November 2023Allow4240YesYes
16838446MAINTAINING INDIVIDUAL IMMUNIZATION RECORDSApril 2020December 2022Allow3210YesNo
16793067SYSTEM AND METHOD FOR ASSISTING TARGET PERSON IN BEHAVIOR CHANGE AND HABITUATIONFebruary 2020November 2022Abandon3320NoNo
16787383Organizational Wellness Delivery and TrackingFebruary 2020April 2022Abandon2610NoNo
16636373PREDICTING, PREVENTING, AND CONTROLLING INFECTION TRANSMISSION WITHIN A HEALTHCARE FACILITY USING A REAL-TIME LOCATING SYSTEM AND NEXT GENERATION SEQUENCINGFebruary 2020June 2022Allow2810NoNo
16736215THERAPY ADJUSTMENT BASED ON PATIENT EVENT INDICATIONJanuary 2020June 2021Allow1810YesNo
16722001Enabling Graphical Illustration Based on Private Medical InformationDecember 2019February 2023Abandon3820YesNo
16620602SYSTEMS AND METHODS OF PREDICTION OF INJURY RISK WITH A TRAINING REGIMEDecember 2019January 2022Abandon2510NoNo
16619293SYSTEMS AND METHODS FOR DYNAMIC MONITORING OF PATIENT CONDITIONS AND PREDICTION OF ADVERSE EVENTSDecember 2019July 2022Abandon3220YesNo
16700312System and Method for Digital Therapeutics Implementing a Digital Deep Layer Patient ProfileDecember 2019December 2021Abandon2510NoNo
16617088SYSTEMS FOR EVALUATING DOSAGE PARAMETERSNovember 2019January 2023Abandon3730YesNo
16691301PSYCHOMETRIC ARTICLE AND METHOD FOR ASSESSING NEUROLOGICAL AND PSYCHOLOGICAL BEHAVIORS THAT IMPACT DECISION MAKINGNovember 2019July 2021Abandon2010NoNo
16654445MANAGING HEALTH CONDITIONS USING PREVENTIVES BASED ON ENVIRONMENTAL CONDITIONSOctober 2019October 2022Allow3630YesNo
16591479SYSTEM AND METHOD FOR TRANSFERRING AND POPULATING PHARMACY DATA INTO A MOBILE APPLICATIONOctober 2019October 2021Abandon2410NoNo
16579857HOSPITAL SUPPORT APPARATUS AND OPERATION METHOD AND OPERATION PROGRAM OF HOSPITAL SUPPORT APPARATUSSeptember 2019March 2024Abandon5460YesNo
16570558METHOD AND APPARATUS FOR PROVIDING REAL-TIME PERIODIC HEALTH UPDATESSeptember 2019December 2023Abandon5150YesNo
16550164FEATURE SELECTION FOR ARTIFICIAL INTELLIGENCE IN HEALTHCARE MANAGEMENTAugust 2019October 2022Allow3720YesNo
16542998APPARATUS, SYSTEM AND METHOD FOR PROCESSING AND SECURING PRESCRIPTION DATA IN A COMPUTER SYSTEMAugust 2019April 2024Allow5640YesNo
16512201MAINTAINING CLINICAL MESSAGING DURING AN INTERNET OUTAGEJuly 2019June 2022Allow3540YesNo
16512252MAINTAINING CLINICAL MESSAGING DURING NETWORK INSTABILITYJuly 2019June 2022Allow3540YesNo
16456510SYSTEMS AND METHODS FOR IDENTIFYING RISK OF INFECTION IN DIALYSIS PATIENTSJune 2019June 2022Allow3620NoNo
16442510SYSTEMS AND METHODS FOR PREDICTING LIKELIHOOD OF MALIGNANCY IN A TARGET TISSUEJune 2019March 2024Abandon5741NoNo
16440319METHODS FOR LOWERING BLOOD PRESSURE WITH A DIHYDROPYRIDINE-TYPE CALCIUM CHANNEL BLOCKER PHARMACEUTICAL COMPOSITIONJune 2019April 2022Allow3420YesNo
16298203USER INTERFACE WITH DYNAMIC DISPLAY OF MATCHING CLINICAL TRIALS AS A PATIENT ANSWERS MORE QUESTIONSMarch 2019July 2021Abandon2810NoNo
16290232Nursing Home Bed ReservationMarch 2019January 2021Abandon2310NoNo
16259135SITUATIONAL DYNAMIC BALANCING OF NUTRITIONJanuary 2019December 2022Abandon4740YesNo
16247369Remote Medical Analysis Systems And MethodsJanuary 2019November 2023Abandon5840NoNo
16317480MULTI-COMMUNICATION PATH SELECTION AND SECURITY SYSTEM FOR A MEDICAL DEVICEJanuary 2019October 2022Allow4540YesNo
16245539SYSTEMS, METHODS AND TECHNIQUES FOR SOCIAL MEDIA MULTI-MODAL HEALTH TECHNOLOGY PLATFORMJanuary 2019July 2021Abandon3010NoNo
16235379METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR UTILIZING BRAIN STRUCTURAL CHARACTERISTICS FOR PREDICTING A DIAGNOSIS OF A NEUROBEHAVIORAL DISORDERDecember 2018January 2022Allow3641YesYes
16175767NATIONAL PATIENT PHARMACY IDENTIFIEROctober 2018January 2021Abandon2710NoNo
16155761METHODS AND APPARATUS FOR EVALUATING DEVELOPMENTAL CONDITIONS AND PROVIDING CONTROL OVER COVERAGE AND RELIABILITYOctober 2018February 2021Abandon2920YesYes
16111855SYSTEMS AND METHODS FOR USING ELECTRONIC MEDICAL RECORDS IN CONJUNCTION WITH PATIENT APPSAugust 2018April 2021Abandon3210NoNo
16074308COGNITIVE PATIENT CARE EVENT RECONSTRUCTIONJuly 2018October 2021Abandon3810NoNo
15996338METHOD, APPARATUS AND SOFTWARE FOR IDENTIFYING RESPONDERS IN A CLINICAL ENVIRONMENTJune 2018March 2021Abandon3410NoNo
15974883METHOD AND SYSTEM FOR GENERATING ESTIMATION DATA FOR POTENTIAL INJURY STATESMay 2018October 2022Abandon5331YesNo
15975565SYSTEM AND METHOD FOR PREVENTING WRONG SITE SURGERYMay 2018August 2020Abandon2710NoNo
15975046MEDICAL DIAGNOSIS SYSTEM WITH CONTINUOUS LEARNING AND REASONINGMay 2018March 2023Allow5960YesNo
15975326METHOD AND APPARATUS FOR RISK ADJUSTMENTMay 2018February 2022Allow4620YesNo
15861224SYSTEMS, METHODS, AND MEDIA FOR GENERATING CLAIM SUBMISSIONSJanuary 2018March 2020Abandon2710YesNo
15790818COMPUTER IMPLEMENTED METHOD FOR DETERMINING CLINICAL TRIAL SUITABILITY OR RELEVANCEOctober 2017March 2019Abandon1720NoNo
15624690PATIENT FLOW TIMER SOFTWAREJune 2017January 2020Abandon3110NoNo
15534253SYSTEM AND METHOD FOR UNIFORMLY CORRELATING UNSTRUCTURED ENTRY FEATURES TO ASSOCIATED THERAPY FEATURESJune 2017July 2021Abandon4970NoNo
15614281SYSTEMS AND METHODS FOR AUTONOMOUS DISCHARGE QUEUE MANAGEMENTJune 2017December 2021Abandon5430YesNo
15584087MOBILE INTEROPERABLE PERSONAL HEALTH INFORMATION EXCHANGE WITH BIOMETRICS DATA ANALYTICSMay 2017November 2022Abandon6060NoYes
15517642DEVICE FOR ANALYZING INSULIN SECRETION ABILITY, SYSTEM FOR ANALYZING INSULIN SECRETION ABILITY PROVIDED WITH SAME, AND METHOD FOR ANALYZING INSULIN SECRETION ABILITYApril 2017October 2022Abandon6060YesNo
15415581METHOD OF AND SYSTEM FOR EXECUTING AN IMPAIRMENT REPAIR PROCESSJanuary 2017September 2023Allow6070NoNo
15394232System and Method for Identifying Inconsistent and/or Duplicate Data in Health RecordsDecember 2016June 2022Abandon6050YesNo
15362642INTERACTIVE PATIENT GUIDANCE FOR MEDICAL DEVICESNovember 2016December 2022Abandon6041YesNo
15308160METHODS AND SYSTEMS FOR DYNAMIC MANAGEMENT OF A HEALTH CONDITIONNovember 2016August 2019Abandon3420NoNo
15307092PATIENT RECRUITMENT SYSTEM AND PATIENT RECRUITMENT METHODOctober 2016December 2023Allow6080YesNo
15129506COMPUTER PROGRAM PRODUCT, SYSTEM AND METHOD FOR PROVIDING AN EMERGENCY AID SERVICE AND PERSONALIZED MANAGEMENT OF HEALTH RECORDSSeptember 2016August 2020Abandon4710NoNo
15271317SYSTEM AND METHOD FOR IDENTIFYING OR ALERTING AN APPROPRIATE EYE CARE PROVIDERSeptember 2016August 2021Abandon5820NoNo
15122204SMART PHONE BASED MULTI-PATIENT WORKLIST (SPWL)August 2016July 2020Abandon4630NoNo
15249415METHOD FOR AUTOMATIC VISUAL ANNOTATION OF RADIOLOGICAL IMAGES FROM PATIENT CLINICAL DATAAugust 2016July 2021Abandon5931NoNo
15247362DETERMINING SOURCES OF HEALTHCARE EXPERTISE RELATED TO A CONDITION OF THE PATIENTAugust 2016September 2021Allow6050YesNo
15119852EVIDENCE-BASED CLINICAL DECISION SYSTEMAugust 2016September 2023Abandon6070NoNo
15119464TRACKING REAL-TIME ASSESSMENT OF QUALITY MONITORING IN ENDOSCOPYAugust 2016July 2021Abandon5950NoNo
15234692SYSTEM AND METHOD FOR CENTRAL VISION ASSESSMENT AND TRACKINGAugust 2016July 2019Abandon3540YesNo
15219769TECHNIQUES FOR PROVIDING LIMITED FIDUCIARY SERVICES FOR SELF-FUNDED HEALTHCARE PLANSJuly 2016June 2019Abandon3520NoNo
15106338LOGGING SYSTEM AND A METHOD OF REGISTERING DATA FOR ENABLING MONITORING OF INTAKE OF A PRODUCT BY A USER ACCORDING TO AN INTAKE PLANJune 2016July 2020Abandon4830NoNo
15105606SCHEDULING DEVICE FOR SCHEDULING PATIENT MONITORING BY PATIENT-ACCESSIBLE DEVICESJune 2016September 2020Abandon5140NoNo
15103958TEST SERVER, COMMUNICATION TERMINAL, TEST SYSTEM, AND TEST METHODJune 2016December 2021Allow6041NoNo
15037636DEVICE AND METHOD FOR PREDICTING SKIN AGE BY USING QUANTIFYING MEANSMay 2016December 2019Abandon4330NoNo
15030705HIERARCHICAL SELF-LEARNING SYSTEM FOR COMPUTERIZED CLINICAL DIAGNOSTIC SUPPORTApril 2016February 2022Allow6041YesYes
15130712SYSTEMS AND METHODS FOR PAIN TRACKINGApril 2016March 2022Allow6041YesYes
15083627MEDICAL SUPPORT DEVICE, METHOD FOR CONTROLLING MEDICAL SUPPORT DEVICE, AND MEDICAL SUPPORT SYSTEMMarch 2016January 2020Abandon4620YesNo
15077135BIOLOGICAL INFORMATION MANAGEMENT SYSTEM AND BIOLOGICAL INFORMATION MANAGEMENT METHODMarch 2016February 2021Abandon5921NoNo
15054047APPOINTMENT SCHEDULING AND CHECK INFebruary 2016August 2020Abandon5320NoYes
15047365System and Method for Determining, Visualizing and Monitoring Coordination of ResourcesFebruary 2016October 2020Abandon5631NoNo
14909652PATIENT MANAGEMENT SYSTEM AND PATIENT MANAGEMENT SERVERFebruary 2016August 2020Allow5530YesNo
15010694MEDICAL SUPPORT SYSTEMJanuary 2016November 2019Abandon4520NoNo
14995440METHOD AND MEDICAL IMAGING APPARATUS FOR EXCHANGE OF DATA BETWEEN THE MEDICAL IMAGING APPARATUS AND A USERJanuary 2016April 2021Abandon6041NoNo
14996157Nursing Home Bed Reservation SystemJanuary 2016January 2019Abandon3620YesNo
14905050COMPUTERIZATION AND VISUALIZATION OF CLINICAL RULES AND DEFINITIONS FOR PATIENT MONITORING SYSTEMSJanuary 2016July 2020Abandon5430NoNo
14990076CUSTOMIZABLE REAL-TIME POINT OF SERVICE UPDATE SYSTEMJanuary 2016January 2019Abandon3601NoNo
14990766ENTITY COHORT DISCOVERY AND ENTITY PROFILINGJanuary 2016April 2019Abandon3910NoNo
14986740COMPREHENSIVE PALLIATIVE AND HOSPICE CARE PLATFORMJanuary 2016December 2018Abandon3601NoNo
14986681Comprehensive website for eye careJanuary 2016September 2018Abandon3310NoNo
14902560Method and Apparatus for Facial Visualization and Dental or Operational PlanningJanuary 2016March 2019Abandon3920NoNo
14986064METHOD, SYSTEM, AND APPARATUS FOR REAL TIME BENEFIT CHECKDecember 2015August 2018Abandon3110NoNo
14984716SYSTEM AND METHOD FOR AUTOMATICALLY GENERATING A HISTORICAL HEALTH TREND GRAPH FOR A PATIENTDecember 2015June 2019Abandon4220NoNo
14757471System and method for adaptive medical decision supportDecember 2015December 2019Abandon4830YesYes
14756891Healthcare universal patient payment gatewaysOctober 2015August 2019Abandon4621YesNo
14756811Clinical information management systemOctober 2015October 2018Abandon3501NoNo
14871942Medical inventory trackingSeptember 2015February 2021Abandon6040YesNo
14870292HEALTHCARE PROTOCOLS AND HEALTHCARE PLANNING SYSTEMS AND METHODSSeptember 2015July 2018Abandon3410NoNo
14871170MEDICAL DIAGNOSTIC-INITIATED INSURANCE OFFERINGSeptember 2015January 2022Abandon6080YesNo
14867994AUTOMATED COMPARATIVE HEALTHCARE, FINANCIAL, OPERATIONAL, AND QUALITY OUTCOMES AND PERFORMANCE BENCHMARKINGSeptember 2015July 2021Allow6060YesNo
14774827Methods and Systems of Real-Time Medication Adherence MonitoringSeptember 2015August 2020Abandon5930YesNo
14852154MEDICAL INFORMATION DISPLAY SYSTEM, SERVER, AND PORTABLE TERMINALSeptember 2015July 2021Abandon6060NoNo
14772213SELECTING A DEVICE TO TREAT DISORDERED BREATHINGSeptember 2015August 2018Abandon3610NoNo
14840421METHOD AND SYSTEM FOR INFORMED CONSENTAugust 2015June 2019Allow4620YesNo
14771427System, Method, and Apparatus for Documenting and Managing Biopsy Specimens and Patient-specific Information On-siteAugust 2015March 2020Allow5540YesNo
14839068System and Method for Storing Health Information and Adjudicating Insurance ClaimsAugust 2015July 2018Abandon3410NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PORTER, RACHEL L.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
35
Examiner Affirmed
28
(80.0%)
Examiner Reversed
7
(20.0%)
Reversal Percentile
33.8%
Lower than average

What This Means

With a 20.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
86
Allowed After Appeal Filing
9
(10.5%)
Not Allowed After Appeal Filing
77
(89.5%)
Filing Benefit Percentile
14.0%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 10.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner PORTER, RACHEL L - Prosecution Strategy Guide

Executive Summary

Examiner PORTER, RACHEL L works in Art Unit 3626 and has examined 382 patent applications in our dataset. With an allowance rate of 18.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 56 months.

Allowance Patterns

Examiner PORTER, RACHEL L's allowance rate of 18.3% places them in the 3% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by PORTER, RACHEL L receive 3.16 office actions before reaching final disposition. This places the examiner in the 87% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PORTER, RACHEL L is 56 months. This places the examiner in the 3% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +21.2% benefit to allowance rate for applications examined by PORTER, RACHEL L. This interview benefit is in the 64% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 7.8% of applications are subsequently allowed. This success rate is in the 4% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 6.0% of cases where such amendments are filed. This entry rate is in the 7% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 34.8% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 35% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 41.7% of appeals filed. This is in the 9% percentile among all examiners. Of these withdrawals, 24.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 51.5% are granted (fully or in part). This grant rate is in the 48% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 2.1% of allowed cases (in the 75% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.9% of allowed cases (in the 75% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.